USEFULNESS OF COMBINATION THERAPY WITH ADALIMUMAB AND IMMUNOMODULATORS IN PATIENTS WITH CROHN’S DISEASE: A LARGE, MULTI-CENTRE COHORT STUDY

Hiroki Tanaka  1     N. Kamata  2     Akihiro Yamada  3     Toshimitsu Fujii  4     Katsuya Endo  5     Takuya Yoshino     Shigeki Bamba     Takeshi Sugaya     Takaaki Kawaguchi     Manabu Ishii     Shinichiro Shinzaki     Yosuke Toya     Yuka Yanai     Yoko Yokoyama     Junji Umeno     Toshihiko Okada     Taku Kobayashi     Masanori Nojima     Toshifumi Hibi    
1 Sapporo Kosei General Hospital,IBD Center,Sapporo,Japan
2 Osaka City University Graduate School of Medicine,Department of Gastroenterology,Osaka,Japan
3 Toho University Sakura Medical Center,Department of Internal Medicine,Sakura,Japan
4 Tokyo Medical and Dental University,Department of Gastroenterology and Hepatology,Tokyo,Japan
5 Tohoku

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing